Kunitz domain peptides

Details Kunitz domain peptides Kunitz domain peptides

2006-01-24

2006-01-24

Wax, Robert A. (Department: 1653)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C530S324000

Reexamination Certificate

active

06989369

ABSTRACT:
The invention relates to a Kunitz domain peptide, designated DPI-14 herein, for inhibiting human neutrophil elastase. The invention also relates to a method of using a DPI-14 for treating cystic fibrosis or cystic fibrosis-related disease or disorder.

REFERENCES:
patent: 4595674 (1986-06-01), Tschesche et al.
patent: 4657893 (1987-04-01), Krantz et al.
patent: 4845242 (1989-07-01), Powers et al.
patent: 4980287 (1990-12-01), Kokubo et al.
patent: 5118668 (1992-06-01), Auerswald et al.
patent: 5166133 (1992-11-01), Houston et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5278144 (1994-01-01), Wolf
patent: 5278285 (1994-01-01), Ebbers et al.
patent: 5373090 (1994-12-01), Norris et al.
patent: 5407915 (1995-04-01), Fritz et al.
patent: 5409895 (1995-04-01), Morishita et al.
patent: 5576294 (1996-11-01), Norris et al.
patent: 5583107 (1996-12-01), Wolf et al.
patent: 5589359 (1996-12-01), Innis et al.
patent: 5663143 (1997-09-01), Ley et al.
patent: 5719041 (1998-02-01), Lazarus et al.
patent: 5736364 (1998-04-01), Kelley et al.
patent: 5770568 (1998-06-01), Auerswald et al.
patent: 5780265 (1998-07-01), Denis et al.
patent: 5786328 (1998-07-01), Denis et al.
patent: 5795865 (1998-08-01), Markland et al.
patent: 5795954 (1998-08-01), Lazarus et al.
patent: 5843895 (1998-12-01), Lazarus et al.
patent: 5994125 (1999-11-01), Markland et al.
patent: 6004579 (1999-12-01), Bathurst et al.
patent: 6010880 (2000-01-01), Markland et al.
patent: 6057287 (2000-05-01), Markland et al.
patent: 6071723 (2000-06-01), Markland et al.
patent: 6087473 (2000-07-01), Conklin et al.
patent: 6103499 (2000-08-01), Markland et al.
patent: 6333402 (2001-12-01), Markland et al.
patent: 6423498 (2002-07-01), Markland et al.
patent: 2003/0175919 (2003-09-01), Ley et al.
patent: 2003/0223977 (2003-12-01), Ley et al.
patent: 2004/0038893 (2004-02-01), Ladner et al.
patent: 2004/0053206 (2004-03-01), Cicardi et al.
patent: 0 195 212 (1986-09-01), None
patent: 0 486 001 (1992-05-01), None
patent: 0 643 075 (1995-03-01), None
patent: WO 90/02809 (1990-03-01), None
patent: WO 92/15605 (1992-09-01), None
patent: WO 93/14120 (1993-07-01), None
patent: WO 93/14121 (1993-07-01), None
patent: WO 93/14122 (1993-07-01), None
patent: WO 03/66824 (2003-08-01), None
Albrecht, G.J., et al., “Elastase Inhibition by the Inter-α Trypsin Inhibitor and Derived Inhibitors of Man and Cattle,”Hoppe-Seyler's Z. Physiol. Chem., 364:1703-1708 (1983).
Albrecht, G.J., et al., “Kunitz-Type Proteinase Inhibitors Derived by Limited Proteolysis of the Inter-α-Trypsin Inhibitor, IX,”Hoppe-Seyler's Z. Physiol. Chem., 364:1697-1702 (1983).
Angelastro, M.R., et al., “α-Diketone and α-Keto Ester Derivatives of N-Protected Amino Acids and Peptides as Novel Inhibitors of Cysteine and Serine Proteinases,”J. Med. Chem., 33:11-13 (1990).
An-Zhi, W., et al., The Refined 2.3 Å Crystal Structure of Human Leukocyte Elastase in a Complex With a Valine Chloromethyl Ketone Inhibitor,FEBS Lett., 234(2):367-373 (1988).
Baek, D.-J., et al., “Alternate Substrate Inhibitors of an α-Chymotrypsin: Enantioselective Interaction of Aryl-Substituted Enol Lactones,”Biochemistry, 29:4305-4311 (1990).
Beckmann, J., et al., “Preparation of Chemically ‘Mutated’ Aprotinin Homologues by Semisynthesis-P1Substitutions Change Inhibitory Specificity,”Eur. J. Biochem., 176: 675-682 (1988).
Blow, D.M., et al., “A Model for the Association of Bovine Pancreatic Trypsin Inhibitor With Chymotrypsin and Trypsin,”J. Mol. Biol., 69: 137-144 (1972).
Brinkmann, T., and Tschesche, H., “Design of an Aprotinin Variant With Inhibitory Activity Against Chymotrypsin and Cathepsin G by Recombinant DNA Technology,”Biol. Chem. Hoppe-Seyler, 371: 43-52 (1990).
Broze, Jr., G.J., et al., “Regulation of Coagulation by a Multivalent Kunitz-Type Inhibitor,”Biochemistry, 29(33):7539-7546 (1990).
Cantor, J.O., and Turino, G.M., “Elastin and Elastases in Lung Disease,” Ch. 16 inElastin and Elastases,II:159-168 (1989).
Carey, F.A., and Sundberg, R.J., Eds. “Multistep Syntheses,” Ch. 13 inAdvanced Organic Chemistry; Part B: Reactions&Synthesis,3rdEd.:678-686 (1990).
Chazin, W.J., et al., “Comparative Studies of Conformation and Internal Mobility in Native and Circular Basic Pancreatic Trypsin Inhibitor by1H Nuclear Magnetic Resonance in Solution,”Eur. J. Biochem., 152:429-437 (1985).
Chen, L., et al., “Identification of a Factor in Fetal Bovine Serum That Stabilizes the Cumulus Extracellular Matrix,”J. Biol. Chem., 267(17): 12380-12386 (1992).
Diarra-Mehrpour, M., et al., “Structural Analysis of the Human Inter-α-Trypsin Inhibitor Light-Chain Gene,”Eur. J. Biochem., 191131-139 (1990).
Dixon, J. S., “Computer-Aided Drug Design: Getting the Best Results,”Trends Biotechnol., 10:357-363 (1992).
Dufton, M.J., “Proteinase Inhibitors and Dendrotoxins,”Eur. J. Biochem., 153: 647-654 (1985).
Engchild, J.J., et al., “Chondroitin 4-Sulfate Covalently Cross-links the Chains of the Human Blood Protein Pre-α-inhibitor,”J. Biol. Chem., 266(2): 747-751 (1991).
Enghild, J.J., et al., “Presence of the Protein-Glycosaminoglycan-Protein Covalent Cross-link in the Inter-α-inhibitor-related Proteinase Inhibitor Heavy Chain 2/bikunin,”J. Biol. Chem., 268(12):8711-8716 (1993).
Engleberg, N.C., et al., “DNA Sequence of mip, aLegionella pneumophilaGene Associated with Macrophage Infectivity,”Infect. Immun., 57(4):1263-1270 (1989).
Escribano, J., et al., “Location and Characterization of the Three Carbohydrate Prosthetic Groups of Human Protein HC,”FEBS Lett., 266(1-2):167-170 (1990).
Escribano, J., et al., “The Protein HC Chromophore Is Linked to the Cystein Residue at Position 34 of the Polypeptide Chain by a Reduction-resistant Bond and Causes the Charge Heterogeneity of Protein HC,”J. Biol. Chem., 266(24):15758-15763 (1991).
Filler, R., “Oxidations and Dehydrogenations with N-Bromosuccinimide and Related N-Haloimides,”Chem. Rev., 63:21-43 (1963).
Ganu, V.S., et al., “Improved Synthetic Inactivators of Plasmin,”Thromb. Res., 45:1-6 (1987).
Gebhard, W., et al., “Structure of Inter-α-Inhibitor (Inter-α-Trypsin Inhibitor) and Pre-α-Inhibitor: Current State and Proposition of a New Terminology,”Biol. Chem. Hoppe-Seyler, 371:13-22 (1990).
Gebhard, W., and Hochstrasser, K., “Inter-α-trypsin inhibitor and its close relatives,” Ch. 11 inProteinase Inhibitors,Barrett and Salvesen (Eds.):389-401 (1986).
Goodman and Gilman,Eds. The Pharmacological Basis of Therapeutics,8thEd. pp 396, 407, 446-449, 473-475, 1117-1125 (Pergamon Press, New York, 1990).
Girard, T.J., et al., “Functional Significance of the Kunitz-type Inhibitory Domains of Lipoprotein-Associated Coagulation Inhibitor,”Nature, 338518-520 (1989).
Goldenberg, D.P., and Creighton, T.E., “Circular and Circularly Permuted Forms of Bovine Pancreatic Trypsin Inhibitor,”J. Mol. Biol. 165: 407-13 (1983).
Goldstein, W., and Doring, G., “Lysosomal Enzymes from Polymorphonuclear Leukocytes and Proteinase Inhibitors in Patients with Cystic Fibrosis,”Am. Rev. Respir. Dis., 13449-56 (1986).
Govardhan, C.P., and Abeles, R.H., “Structures-Activity Studies of Fluoroketone Inhibitors of α-Lytic Protease and Human Leukocyte Elastase,”Arch. Biochem. Biophys., 280(1):137-143 (1990).
Heidtmann, H., and Travis, J., “Human α1-Proteinase Inhibitor,” Ch. 14 inProteinase Inhibitors,Barrett and Salvesen (Eds.):441-456 (1986).
Xu, Y., et al., “The Crystal Structure of Bikunin from the Inter-α-Inhibitor Complex: A Serine Protease Inhibitor with Two Kunitz Domains,”J. Mol. Biol., 276:955-966 (1998).
Hochstrasser, K., et al., “Kunitz-Type Proteinase Inhibitors Derived by

Affiliated with

Also associated with

Rating

Kunitz domain peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Kunitz domain peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kunitz domain peptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3565324